Td Private Client Wealth LLC Novo Cure LTD Transaction History

Td Private Client Wealth LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2024	SELL	$56.6 - $89.9 $5,377 - $8,540	-95 Closed	0 $0
Q1 2022 Aug 16, 2024	BUY	$60.15 - $84.52 $5,714 - $8,029	95 New	95 $7.87 Million
Q4 2021 Aug 16, 2024	SELL	$75.08 - $121.99 $825 - $1,341	-11 Closed	0 $0
Q3 2021 Aug 16, 2024	BUY	$116.17 - $194.55 $1,277 - $2,140	11 New	11 $1.28 Million

264

78.9M

751K

293K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.83B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Td Private Client Wealth LLC with notifications on news.